Skip to content
Fowler Lab
Fowler Lab

Predicting antimicrobial resistance

  • News
  • Publications
  • Members
  • Research
    • Overview
    • Manifesto
    • Software
    • Reproducibility
  • Teaching
  • Contact
    • PhDs
  • Wiki
Fowler Lab
Fowler Lab

Predicting antimicrobial resistance

New Publication: Structure of MmpL3

Philip Fowler, 21st July 202121st July 2021

Oliver Adams successfully elucidated the structure of the M. tuberculosis MmpL3 membrane transporter using cryo-EM and this has recently been published online in Structure. This was the main aim of his PhD studies in Simon Newstead‘s group in the Department of Biochemistry here in Oxford.

It is an important protein structure since although other MmpL3 structures have been solved, this is the first one from M. tuberculosis and, as the only essential member of the MmpL family, is targeted by a number of drugs under development, for example SQ109 which is currently in Phase 2 clinical trials. Being able to see how the drug interacts with the protein can help us understand a variety of effects, from binding to resistance.

Share this:

  • Share on X (Opens in new window) X
  • Share on Bluesky (Opens in new window) Bluesky
  • Email a link to a friend (Opens in new window) Email
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Mastodon (Opens in new window) Mastodon

Related

antimicrobial resistance publication research tuberculosis

Post navigation

Previous post
Next post

Related Posts

antimicrobial resistance

CRyPTIC datasets available through new website

25th June 20257th July 2025

The CRyPTIC project ran from 2016 to 2022 and collected >20,000 clinical samples from patients…

Share this:

  • Share on X (Opens in new window) X
  • Share on Bluesky (Opens in new window) Bluesky
  • Email a link to a friend (Opens in new window) Email
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Mastodon (Opens in new window) Mastodon
Read More

Gr-ADI consortium announced

22nd January 2026

Pleased and excited to be a small part of the Gram-Negative Antibiotic Discovery Innovator (Gr-ADI)…

Share this:

  • Share on X (Opens in new window) X
  • Share on Bluesky (Opens in new window) Bluesky
  • Email a link to a friend (Opens in new window) Email
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Mastodon (Opens in new window) Mastodon
Read More
antimicrobial resistance

Postdoctoral position advertised

17th May 202117th May 2021

Through the CompBioMed2 EU Centre of Excellence project I have funding to appoint a postdoctoral…

Share this:

  • Share on X (Opens in new window) X
  • Share on Bluesky (Opens in new window) Bluesky
  • Email a link to a friend (Opens in new window) Email
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Mastodon (Opens in new window) Mastodon
Read More

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.

To find out more, including how to control cookies, see here: Cookie Policy
    ©2026 Fowler Lab | WordPress Theme by SuperbThemes